Medicare Would Share Drug Data – But Not Prices – With FDA, Private Research Groups, Under Grassley/Baucus Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
Senate Finance Committee Chairman Grassley introduces the "Medicare Data Access and Research Act" to help Medicare share data with FDA and other public health agencies.
You may also be interested in...
Editor's Note: Please Help Pink Sheet Serve You Best
Please take our brief reader survey to help us better understand your content and delivery needs.
Editor’s Choice: Notable Pink Sheet Articles From Q3
A must-read selection of intriguing and popular articles posted in the Pink Sheet over the past three months.
Policy Prescriptions: Kite's CAR-T; Price And Value Scrutiny; Biosimilars; Manufacturing Missteps
Kite's CAR-T application seems to be sailing ahead without US FDA AdComm review; large employers in the US look into value-based contracting while European regulators band together on joint price negotiations; Teva is back at FDA with its EpiPen application. Policy Prescriptions rounds up recent regulatory news and trends reported by sister publication the Pink Sheet.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: